Insulet appoints new CEO, anticipates revenue surpassing expectations, shares decrease

From Yahoo Finance: 2025-04-28 10:00:00

Insulet, the maker of the Omnipod insulin pump, announced that Ashley McEvoy will replace Jim Hollingshead as CEO. The company also plans to exceed its revenue estimates for the current quarter and full year. Insulet is set to release its first quarter earnings report on May 8. Despite the positive outlook, Insulet’s shares edged lower as the leadership shakeup was revealed. McEvoy, who previously worked at Johnson & Johnson, was chosen for her expertise in the MedTech market. The company expects strong revenue growth for the first quarter and full year. Shares of Insulet have remained stable year-to-date.



Read more at Yahoo Finance: Insulet Names New CEO, Expects to Top Revenue Projections